GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 137 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2017. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $12,687,000 | +317075.0% | 186,080 | +193733.3% | 0.01% | – |
Q1 2021 | $4,000 | -88.9% | 96 | -88.0% | 0.00% | – |
Q4 2020 | $36,000 | -55.0% | 803 | -38.7% | 0.00% | – |
Q3 2020 | $80,000 | +86.0% | 1,310 | +115.8% | 0.00% | – |
Q2 2020 | $43,000 | +10.3% | 607 | -21.6% | 0.00% | – |
Q1 2020 | $39,000 | -94.4% | 774 | -91.2% | 0.00% | -100.0% |
Q4 2019 | $695,000 | +65.9% | 8,747 | +1.4% | 0.00% | – |
Q3 2019 | $419,000 | +36.5% | 8,630 | +47.7% | 0.00% | – |
Q2 2019 | $307,000 | +553.2% | 5,841 | +567.5% | 0.00% | – |
Q1 2019 | $47,000 | -27.7% | 875 | -44.7% | 0.00% | – |
Q4 2018 | $65,000 | +75.7% | 1,582 | +61.9% | 0.00% | – |
Q3 2018 | $37,000 | -15.9% | 977 | -1.0% | 0.00% | – |
Q2 2018 | $44,000 | +22.2% | 987 | +31.6% | 0.00% | – |
Q1 2018 | $36,000 | -81.9% | 750 | -85.1% | 0.00% | – |
Q4 2017 | $199,000 | -46.1% | 5,050 | -57.6% | 0.00% | – |
Q3 2017 | $369,000 | -12.4% | 11,900 | -22.7% | 0.00% | – |
Q2 2017 | $421,000 | -29.5% | 15,400 | -4.9% | 0.00% | -100.0% |
Q1 2017 | $597,000 | +637.0% | 16,200 | +548.0% | 0.00% | – |
Q4 2015 | $81,000 | -52.1% | 2,500 | -37.5% | 0.00% | – |
Q3 2015 | $169,000 | – | 4,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |